At PsychoGenics, we understand the complexities disease research foundations encounter in their pursuit of developing treatments. Our decades-long partnerships with many disease research foundations have equipped us with a deep understanding of the unique challenges associated with disease-specific discovery.
With our extensive expertise, we will help you evaluate and/or validate the best rodent disease models and identify translational endpoints to assess promising treatments.
Our Foundation Partners
Disease Foundations
- Charcot-Marie-Tooth Association
- CHDI Foundation
- The Michael J. Fox Foundation
- SMA Foundation
- TSC Alliance
- Other disease research foundations
Unleash the Full Potential of Your Research
Accelerate your discovery programs with our cutting-edge approach to research, including our AI-driven drug discovery platforms and analytical tools. Our extensive capabilities, customized solutions, and studies are designed to address the specific goals of your discovery programs.
PsychoGenics researchers’ broad expertise spans diverse testing approaches, with a focus on optimal study design and data interpretation. Our specialty lies in identifying statistically relevant phenotypic changes in rodent disease models and tractable endpoints to enhance the reproducibility and translatability to the clinic.
Your industry and academic drug discovery partners know they can trust a rodent model phenotype when PsychoGenics has done the characterization.